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Postmenopausal period has been associated to different symptoms such as hot
flashes, vulvovaginal atrophy, hypoactive sexual desire disorder (HSDD) and others.
Clinical studies have described postmenopausal women presenting HSDD can benefit
from the association of testosterone to conventional hormonal therapy. Testosterone
has been linked to development of cardiovascular diseases including hypertension
and it also increases cytochrome P-450-induced 20-HETE synthesis which in turn
results in vascular dysfunction. However, the effect of testosterone plus estrogen
in the cardiovascular system is still very poorly studied. The aim of the present
study is to evaluate the role of cytochrome P-450 pathway in a postmenopausal
hypertensive female treated with testosterone plus estrogen. For that, hypertensive
ovariectomized rats (OVX-SHR) were used as a model of postmenopausal hypertension
and four groups were created: SHAM-operated (SHAM), ovariectomized SHR (OVX),
OVX treated for 15 days with conjugated equine estrogens [(CEE) 9.6 µg/Kg/day/po]
or CEE associated to testosterone [(CEE+T) 2.85 mg/kg/weekly/im]. Phenylephrine-
induced contraction and generation of reactive oxygen species (ROS) were markedly
increased in aortic rings from OVX-SHR compared to SHAM rats which were restored
by CEE treatment. On the other hand, CEE+T abolished vascular effects by CEE and
augmented both systolic and diastolic blood pressure of SHR. Treatment of aortic
rings with the CYP/20-HETE synthesis inhibitor HET0016 (1 µM) reduced phenylephrine
hyperreactivity and the augmented ROS generation in the CEE+T group. These results
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are paralleled by the increased CYP4F3 protein expression and activity in aortas of
CEE+T. In conclusion, we showed that association of testosterone to estrogen therapy
produces detrimental effects in cardiovascular system of ovariectomized hypertensive
females via CYP4F3/20-HETE pathway. Therefore, our findings support the standpoint
that the CYP/20-HETE pathway is an important therapeutic target for the prevention
of cardiovascular disease in menopausal women in the presence of high levels of
testosterone.
Keywords: testosterone and estrogen treatment, spontaneously hypertensive rat (SHR), cardiovascular disease,
vascular reactivity, ROS generation, cytochrome P-450 pathways, 20-HETE
INTRODUCTION
The postmenopausal period has been associated to reduction
of plasma estrogen levels and different symptoms such as hot
flashes, vulvovaginal atrophy, hypoactive sexual desire disorder
(HSDD) and others. At the moment, estrogen therapy is the most
effective intervention for hot flashes and improves vulvovaginal
atrophy symptoms (Leiblum et al., 2006; Hayes et al., 2007;
Shifren et al., 2008; Takahashi and Johnson, 2015), but not HSDD.
Hypoactive sexual desire disorder affects 40% of
postmenopausal women (Hayes et al., 2007; Shifren et al.,
2008) and, for that reason, testosterone has been used with
increasing frequency to treat this condition (Dennerstein et al.,
2006; Leiblum et al., 2006; Achilli et al., 2016; Shifren and
Davis, 2017). However, little is known how this therapy affects
the cardiovascular system of menopausal women. Elevated
androgen concentrations in natural menopause and polycystic
ovary syndrome have been associated with higher incidence
of cardiovascular disease (Rexrode et al., 2003; Yanes and
Reckelhoff, 2011; Daan et al., 2015). We recently described
that testosterone treatment at clinical dose increases blood
pressure and aggravates vascular dysfunction in a rat model of
hypertensive menopause (Costa et al., 2015).
Among mechanisms to explain the detrimental effects
of testosterone on cardiovascular disease, direct actions
in the vasculature have been reported such as modulation
of cytochrome P-450, cyclooxygenase products, oxidative
stress and 20-HETE synthesis (Wu and Schwartzman, 2011;
Lopes et al., 2012; Tostes et al., 2015). Cytochrome P450
enzymes of the 4A (CYP4A) and 4F (CYP4F) subfamilies
catalyze the ω-hydroxylation of arachidonic acid and produce
epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatetraenoic
acids (DiHETEs), such as 20-hydroxyeicosatetraenoic acid
(20-HETE) (Capdevila et al., 1981; Morrison and Pascoe,
1981; Oliw et al., 1981). Sex-dependent expression and
regulation by androgens has been a key feature of CYP4A
enzymes (Holla et al., 2001; Yanes et al., 2011; Wu et al.,
2013). In fact, CYP4A-derived 20-HETE activity has been
increased in either cerebral microvessels from aged female
spontaneously hypertensive rats (SHR) (Yanes et al., 2011) or
renal microvessels from female normotensive Sprague-Dawley
rats with dihydrotestosterone supplementation (Dalmasso et al.,
2016).
20-HETE contributes to the regulation of vascular function
(Imig, 2016), mainly in the microvasculature (Harder et al.,
1994). In those vessels, 20-HETE has been described as a
potent vasoconstrictor that induces vascular smooth muscle
cell depolarization through inhibition of potassium channel
(KCa), protein kinase C (PKC) (Lange et al., 1997), Rho
Kinase activation (Randriamboavonjy et al., 2003). 20-HETE
also increases sensitization of the contractile apparatus to Ca2+
(Randriamboavonjy et al., 2003, 2005), inhibits Na+-K+-ATPase
(Ominato et al., 1996; Nowicki et al., 1997), as well as impairs
the NO-dependent vasodilatation (Alonso-Galicia et al., 1999;
Sun et al., 2000; López et al., 2001) and cGMP/NO-independent
vasodilatation (López et al., 2001). Besides 20-HETE may play
a central role in vascular remodeling by inducing vascular
smooth muscle cell growth, proliferation and differentiation
via calcium/calmodulin dependent protein kinase II, leading to
activation of mitogen-activated protein kinase signaling pathway
(Muthalif et al., 1998). However, as far as we know, the role of
20-HETE in large vessel function is not completely understood.
Recently, increased 20-HETE levels have been related to the
development of cardiovascular disease, such as stroke (Huang
et al., 2016; Yi et al., 2016a), coronary heart disease (Miyata
and Roman, 2005), arterial dysfunction (Berezan et al., 2008)
atherosclerosis (Yi et al., 2016b,c) and hypertension (Williams
et al., 2010). Postmenopausal women are at greater risk to suffer
from these diseases, and testosterone could further increase this
risk. In this regard, in the present study we determined the
role of a clinically relevant dose of testosterone associated to
estrogen conventional therapy in vascular function of aorta of
ovariectomized SHR, a model of postmenopausal hypertension,
and how 20-HETE could contribute to effects induced by
testosterone.
MATERIALS AND METHODS
Animal Model
Female spontaneously hypertensive rats (SHR) were obtained
from the breeding stock of the Institute of Biomedical Sciences
of the University of São Paulo (ICB-USP) and maintained
in a temperature-controlled room on a 12-h light/dark cycle,
60% humidity and standard rat chow and water ad libitum.
This study was approved by the Institutional Animal Ethics
Committee of the ICB-USP (Protocol 145, page 95, book 2.
06.12.2013), following the Guide for the Care and Use of
Laboratory Animals published by the US National Institute of
Health (NIH Publication No. 85-23, revised 1996).
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Ovariectomy, Estrogen, and
Testosterone Treatment
Rats were ovariectomized (OVX) or SHAM-operated (SHAM) at
12 weeks of age under with a mixture of ketamine (113 mg/kg)
and xylazine (7.4 mg/kg). Thirty days after ovariectomy, a
group of OVX rats was treated during 15 days with a
solution of conjugated equine estrogens (CEE) (Premarin R©,
9.6 µg/Kg/day; p.o.) by gavage as previously described (Ceravolo
et al., 2012; Araujo et al., 2017). Another OVX group received
CEE (9.6 µg/Kg/day) associated with testosterone cypionate
(2.85 mg/kg/weekly, im; CEE+T) as reported (Ramos et al., 2007;
Costa et al., 2015). At the end of the treatment period, rats were
anesthetized (sodium thiopental, 40 mg/Kg; i.p.), blood samples
were collected from the abdominal aorta and then centrifuged
to separate the serum. Serum levels of estrogen and testosterone
were determined by a commercial ELISA kit (Cayman Chemical,
United States).
Arterial Blood Pressure Measurement
Female rats were anasthetized with ketamine (113 mg/Kg;
i.p.) and xylazine (7.4 mg/Kg; i.p.), a heparinized polyethylene
catheter was inserted into the right carotid artery and the catheter
was exteriorized in the mid-scapular region. After a 24-h recovery
period, systolic and diastolic blood pressures were measured in
conscious animals by a pressure transducer (Deltran DPT-100,
Utah Medical Products, United States) and recorded using an
interface and software for computer data acquisition (PowerLab,
ADInstruments, Melbourne, VIC, Australia).
Vascular Reactivity
Endothelium-intact segments (4 mm) of descending thoracic
aorta were carefully dissected to remove excess of fat and
connective tissue in ice-cold Krebs solution (in mM: 118 NaCl,
4.7 KCl, 25 NaHCO3, 2.5 CaCl2-2H2O, 1.2 KH2PO4, 1.2 MgSO4-
7H2O, 11 glucose and 0.01 EDTA), and gassed with 95% O2 and
5% CO2. Two stainless steel hooks were inserted into the lumen
of the vessel and set up in an organ bath for measurement of
isometric contractile force. The vessels were prepared essentially
as previously described (Carvalho et al., 1987). Thoracic aorta
segments were submitted to a tension of 1.5 g (Ceravolo et al.,
2007). After a 60-min equilibration period, thoracic aortic rings
were initially exposed to 90 mM KCl to determine the functional
integrity of smooth muscle cells. Contractile responses mediated
by α1-adrenoceptor stimulation were studied by evaluating
cumulative concentration-response curves to phenylephrine
(Phenyl: 0.1 nM to 10 µM). In another series of experiments,
the influence of 20-HETE on Phenyl responses was evaluated by
adding N-hydroxy-N′-(4-butyl- 2-methylphenyl)-formamidine
(HET0016 – 1 µM; Cayman Chemical, United States – product
number 75780), an inhibitor of the CYP4A and CYP4F, to the
organ bath 30 min before the concentration-response curves
to Phenyl. HET0016 was diluted in DMSO:PBS (pH 7,2; 1:1)
solution, and the concentration was chosen on the basis of
previous studies (Yousif and Benter, 2010). Similar concentration
of DMSO was used in untreated (Control) arteries.
Detection of Reactive Oxygen Species
(ROS) Generation in Aortic Sections
Vascular ROS detection was determined in situ in thoracic aortic
sections by dihydroethidium (DHE). Before aortas were frozen
in freezing medium, they were incubated with HET0016 (1 µM)
or vehicle (basal group) for 30 min in Krebs solution at 37◦C.
Cross sections of aorta (10 µm) were incubated in a light-
protected and humidified chamber (37◦C, 30 min) with DHE
(5 µM) and fluorescence was detected with a 585–590 nm
long-pass filter, under a microscope (Nikon, Japan) with a 40×
objective lens coupled to a digital camera. Fluorescent images
were recorded and analyzed by measuring the mean optical
density of the fluorescence using an imaging software (Image J,
NIH, United States). Fluorescence was evaluated in each image at
least in four locations and normalized by the area.
Immunoblot Analysis
Frozen thoracic aorta was homogenized in RIPA lysis buffer
(Thermo Fisher Scientific) [50 mmol/L of Tris/HCl (pH 7.4), 1%
Igepal, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA,
2µg/ml protease inhibitor] and centrifuged at 14000 g for 30 min
at 4◦C. Equal amount of protein (30 µg) from each aorta was
resolved by SDS-PAGE on 4–12% gels and electroblotted onto
nitrocellulose membrane. Membranes were incubated overnight
at 4◦C with 1:1000 dilution of polyclonal CYP4A1 and CYP4F3
antibodies (Biorbyt, Cambridge, United Kingdom). After that,
membranes were incubated for 1 h with a 1:2000 dilution
of horseradish peroxidase-labeled goat anti-rabbit secondary
antibody (Thermo Scientific, Waltham, MA, United States)
and chemiluminescent signal was visualized by ImageQuant
LAS 4000 imaging system (GE Headquarter Life Science,
Marlborough, MA, United States). Densitometric analyses of
immunoblots were performed using an imaging software (Image
J, NIH, United States), and CYP4A1 and CYP4F3 band densities
were normalized by densitometry of α-actin (1:2000 – Dako).
Quantitative Real-Time PCR (qPCR)
Analysis
Total RNA was isolated from aortas using TRizol R© Reagent
according to the manufacturer’s instructions. mRNAs encoding
the CYP4A1 and CYP4F3 were quantified by qPCR using
Fast SYBR R© Green Master Mix (Thermo Fisher Scientific,
MA, United States). GAPDH was used as an internal control.
qPCR reactions were performed, recorded, and analyzed using
the Corbett Research system (Corbett Life Sciences, Sydney,
Australia). The conditions for qPCR were as follows: 95◦C
for 20 s, 40 cycles of 95◦C for 3 s and 60◦C for 30 s. Cycle
threshold (Ct) values obtained for each gene were referenced
to GAPDH (1Ct) and converted to the linear form using
the term 2−11Ct as a value directly proportional to the copy
number of complementary DNA and initial quantity of mRNA.
Primer sequences: CYP4A1 F: CGACACAGCCACTCATTCCT;
R: TCAGGGCCACAATCACCTTC (97pb) (NM_175837.1);
CYP4F3 F: GTGCGTCTTCAGCTTTGACAG; R: GTCCACAT
GCAGAAGCAGACT (118pb) (NM_001033686.1); GAPDH
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F: GGGCAGCCCAGAACATCAT; R: CCGTTCAGCTCTGGGA
TGAC (76bp) (NM_017008.4).
Activity of CYP Enzymes and 20-HETE
Concentration
Thoracic aortas were homogenized in ice-cold PBS with 2 µg/ml
protease inhibitors. Total protein amount was determined by
Qubit fluorometric quantitation (Thermo Fisher Scientific).
Assays for activity of CYP4A1 and CYP4F3 were performed using
the instructions in the P450-GloTM Assay (Promega, Madison,
WI, United States). Biochemical assays were assembled and
performed in opaque white 96-well plates, and reactions were
incubated with specific CYP substrates 100 µM Luciferin-ME
(CYP4A1) or 50 µM Luciferin-4F2/3 (CYP4F3) for 30 min at
37◦C. After incubation period, 50 µl of Luciferin Detection
Reagent was added to each well to terminate the reaction and
initiate luminescence. Luminescence was detected every 5 min
for 30 min using a Synergy multi-mode plate reader (BioTek
Instruments, Winooski, VT, United States). Data was normalized
by the amount of protein in each sample and expressed as the
percentage (%) of luminescence emitted by recombinant human
CYP4A1 or CYP43F with P450 reductase (SupersomesTM, BD
Biosciences). In another series of experiments, the concentration
of 20-HETE was determined in aortic homogenates with a
commercially available ELISA kit (Detroit R&D, Detroit, MI,
United States). 20-HETE levels were expressed as ng/ml and
normalized by the total amount of protein.
Statistical Analysis
Data were expressed as means ± SEM (Standard Error of the
Median). The number (n) of rats used in each experiment
was indicated in the figure legends. Phenyl vasoconstriction
was expressed as delta of contraction subtracted from the
initial tension. Area under curve (AUC) was calculated from
each individual concentration-response curve and expressed as
arbitrary units. Differences among groups (SHAM, OVX, CEE
and CEE+T) were analyzed by one-way ANOVA with Tukey
post hoc test. Statistical significance was accepted at p < 0.05.
The statistical analysis was carried out using the Prism 5 software
(GraphPad Software Inc., San Diego, CA, United States).
RESULTS
Uterine Weight, Sex Steroid Hormone
Levels and Arterial Blood Pressure
Ovariectomy reduced significantly uterine weight and plasma
estrogen level when compared to the SHAM female rats and
were restored by CEE and CEE+T treatments. Testosterone level
was increased significantly in the CEE+T group compared to all
groups (Table 1). The systolic and diastolic arterial pressures of
female SHR were neither modified by ovariectomy nor by CEE
treatment. However, the association of testosterone with CEE
markedly increased systolic arterial pressure compared to the
SHAM, OVX, and CEE groups and increased diastolic arterial
pressure compared to the SHAM and OVX groups (Figure 1).
Vascular Reactivity
Phenyl contracted thoracic aortic rings in a concentration-
dependent manner (Figure 2A). Contractions induced by Phenyl
were increased in aortic rings from OVX group in comparison to
SHAM group (Figure 2B). CEE treatment reduced the Phenyl-
contractile response in aorta isolated from OVX-SHR, restoring
the vascular responses to similar levels of aortas from SHAM
rats. However, the protective effects of CEE were abolished
when testosterone was associated to CEE treatment in OVX-SHR
(Figure 2B).
In order to evaluate the contribution of 20-HETE to the
increased vasoconstriction observed in OVX and CEE+T groups,
Phenyl contractions were performed in the presence of HET0016
(1 µM), a CYP4A and CYP4F inhibitor. Addition of HET0016
to the organ bath did not interfere with Phenyl-induced
vasoconstriction in SHAM aortic rings (Figure 2C). On the other
hand, inhibition of CYP4A and CYP4F by HET0016 reduced
Phenyl-induced constriction in aorta isolated from OVX, CEE,
and CEE+T groups, respectively (Figures 2D–F). The delta
analysis of these effects showed that HET0016-induced reduction
in Phenyl contractions were greater in the OVX compared
to the SHAM group and did not change in the CEE group.
In contrast, the decrease in Phenyl contractions, induced by
HET0016, was greater in CEE+T than SHAM and CEE groups
(Figure 2G).
ROS Detection
An increase in ROS levels was detected in aorta isolated from
OVX compared to aorta of the SHAM group (Figure 3A).
CEE treatment reduced ROS production in aortas of OVX
to similar level observed in aorta of the SHAM group.
Nevertheless, the association of testosterone to CEE abolishes
this effect of CEE, maintaining the levels of ROS similar to
those observed in OVX (Figure 3B). Treatment of aortas with
HET0016 (1 µM), a CYP4A and CYP4F inhibitor, reduced
ROS generation only in aorta isolated from the CEE+T group
(Figure 3C).
CYP4A1 and CYP4F3 Protein and mRNA
Expression
Ovariectomy increases protein expression of CYP4A1 in aorta of
SHR. CEE+T, but not CEE alone, decreases CYP4A1 expression
compared to OVX to the similar level of the SHAM group
(Figure 4A). On the other hand, in aorta of OVX the CYP4F3
protein expression level were similar to the ones observed in
SHAM. CYP4F3 expression was augmented by CEE treatment
in comparison to OVX group, and further increased by CEE+T
(Figure 4B). mRNA levels of CYP4A1 follow the same pattern
of protein expression in SHR aortas (Figure 5A). However,
mRNA levels of CYP4F3 in the aorta of OVX are marked
decreased compared to the levels observed in SHAM. The
CEE treatment augmented the CYP4F3 in OVX group, while
the association of testosterone to CEE treatment decreased
CYP4F3 mRNA levels above the levels observed in OVX
(Figure 5B).
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TABLE 1 | Uterine weight and sex steroid hormone levels in SHAM, ovariectomized (OVX), OVX treated with conjugated equine estrogens (CEE) and OVX treated with
CEE plus testosterone (CEE+T) female spontaneously hypertensive rats.
Sham ovx CEE CEE+T
Wet uterus weight (g/cm tibia) 0.117 ± 0.01 0.016 ± 0.1∗ 0.086.3 ± 0.1# 0.085 ± 0.1#
Dry Uterus weight (g/cm tibia) 0.036 ± 0.01 0.007 ± 0.01∗ 0.024 ± 0.01# 0.033 ± 0.01#
Plasma estrogen (pg/ml) 37.8 ± 3.1 13.7 ± 1.2∗ 74.0 ± 13.3∗# 41.8 ± 7.1∗#
Plasma testosterone (ng/ml) 13.6 ± 4.4 6.5 ± 0.4 6.5 ± 0.5 29.7 ± 6.1∗#+
Results are expressed as mean ± SEM of 5–6 animals/group. One-way ANOVA: ∗P < 0.05 versus SHAM; #P < 0.05 versus OVX; +P < 0.05 versus CEE.
FIGURE 1 | Systolic and diastolic arterial blood pressure (mmHg) were obtained from SHAM, ovariectomized (OVX), OVX treated with conjugated equine estrogens
(CEE) and OVX treated with CEE plus testosterone (CEE+T) female spontaneously hypertensive rats. Results represent the mean ± SEM from 6 to 8 animals/group.
One-way ANOVA: ∗P < 0.05.
CYP4A1 and CYP4F3 Activity and
20-HETE Concentration in Rat Aorta
Luminescent signals for Luciferin-ME or Luciferin-4F2/3 was
specific for recombinant CYP4A1 or CYP4F3, respectively
(Figures 6A,B), and completely abolished (∼90% decrease) in
the presence of 1 µM HET0016 (data not shown). The activity of
CYP4A1 was increased in aortic homogenate of OVX compared
to SHAM. CEE treatment did not modify CYP4A1 activity
in OVX, although the association of CEE with testosterone
markedly decreased CYP4A1 activity (Figure 6A). As for CYP4F3
activity, only aortas from OVX treated with CEE+T presented a
significant increase in relation to the other groups (Figure 6B).
The increase in CYP4F3 activity was paralleled with an increase
of 20-HETE levels in aortic tissue (Figure 6C).
DISCUSSION
The benefits of treatment with testosterone in HSDD have
been known for a long time (Palacios, 2011) and strengthened
by randomized controlled data supporting its use (Woodis
et al., 2012). However, important unanswered questions in the
cardiovascular system still exist.
In this study, we demonstrated that association of a clinically
relevant dose of testosterone to CEE therapy induces Phenyl-
hyperreactivity and increases ROS generation by a mechanism
involving CYP4F3-derived 20-HETE synthesis (Figure 7). Those
findings added important mechanistic information to previous
study showing that the association of testosterone to CEE
abolishes the vascular protective effect of estrogens in aorta of
ovariectomized SHR, a model of postmenopausal hypertension
(Costa et al., 2015).
Elevated androgen/testosterone levels have been linked to
the development of hypertension (Lopes et al., 2012; Tostes
et al., 2015), therefore we hypothesized that treating hypertensive
females with testosterone could interfere with blood pressure
levels, worsening hypertension. We found that ovariectomy and
CEE treatment does not alter systolic and diastolic blood pressure
compared to that observed in intact (SHAM) hypertensive female
rats. Nevertheless, the association of testosterone to estrogen
therapy markedly increased blood pressure in hypertensive OVX
females, confirming previous data of our group (Costa et al.,
2015). Besides, hormone-mediated and sex-associated differences
in control of blood pressure has been reported in several
experimental models of hypertension (Reckelhoff et al., 1998;
Reckelhoff and Granger, 1999; Reckelhoff, 2001) and a significant
correlation between androgen levels and the development of
hypertension and other cardiovascular disease has been well
reviewed by Liu et al. (2003).
Androgen receptors are widely distributed in the vascular
tissues, both in the vascular endothelium and smooth muscle
cells (Lopes et al., 2012), and therefore testosterone could
modulate arterial pressure by a direct modulation of vascular
function. Testosterone has been associated with potentiation of
vasoconstriction elicited by angiotensin II (Chen et al., 1992;
Reckelhoff et al., 2000; Sartori-Valinotti et al., 2008; Yanes et al.,
2009), increased thromboxane production by cyclooxygenase
(Song et al., 2004; Gonzales et al., 2005) and Cyp4A/
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FIGURE 2 | Cumulative Concentration-Response Curves (CCRC) to phenylephrine (Phe) (A) and area under curve (AUC) to Phenyl (B), in endothelium-intact aorta
from SHAM, ovariectomized (OVX), OVX treated with conjugated equine estrogens (CEE) and OVX treated with CEE plus testosterone (CEE+T) female spontaneously
hypertensive rats. CCRC to Phenyl in the presence of HET0016, the CYP4A and CYP4F inhibitor, in aorta from SHAM (C), OVX (D), CEE (E), and CEE+T (F) rats.
Difference of AUC in the absence and presence of HET0016 (G). Results represent the mean ± SEM from 6 to 8 independent experiments. ∗P < 0.05.
20-HETE activation (Holla et al., 2001; Skott, 2003; Singh and
Schwartzman, 2008; Lopes et al., 2012). In fact, the role of
20-HETE inhibition by HET0016 in blood pressure has been
described. Yanes et al. (2011) demonstrated that in aged female
spontaneously hypertensive, as a model of postmenopausal
hypertension, acute intravenous infusion of HET0016 also
reduced blood pressure and Toth et al. (2013) demonstrate that
5 days of treatment with HET0016 can reduce blood pressure in
male spontaneously hypertensive rats.
We demonstrate that association of testosterone to estrogen
therapy abolished the beneficial effects of CEE treatment in
aortas of OVX-SHR, by increasing adrenergic vasoconstriction.
Supporting our data are previous studies showing that
testosterone enhances vasoconstriction responses to different
agonists (Khalil, 2005; Chinnathambi et al., 2014a,b), even when
it is associated with estrogen therapy (Costa et al., 2015).
The arachidonic acid ω-hydroxylase metabolite 20-HETE
promotes vasoconstriction and increases vascular resistance
(Alonso-Galicia et al., 1999; Miyata and Roman, 2005), and
previous studies have established 20-HETE as an important
mediator in the vasoconstriction induced by endothelin (Hercule
and Oyekan, 2000) and angiotensin II (Croft et al., 2000; Joly
et al., 2006). We observed that the hyperactivity to Phenyl,
when OVX-SHR where treated with the association CEE+T, was
partially mediated by 20-HETE, since acute inhibition of aortas
with HET016 markedly decreased Phenyl contractions (1 AUC).
The HET0016 is an inhibitor of 20-HETE formation. (Miyata
et al., 2001) have shown that the HET0016 potently and
selectively inhibited the production of 20-HETE in microsomal
renal by inhibited different CYP isoforms. We utilized the
concentration similar to (Yousif and Benter, 2010), because that
is efficient for decrease phenylephrine induced-vasoconstriction
in microvessels of SHR and Wistar Kyoto.
Many factors may contribute to changes in 20-HETE
concentration in the vasculature, among them are sex hormones
(Coon, 2005). Moreover, in non-vascular tissues up-regulation
of CYP4A expression by estrogen has been also observed
(Hiratsuka et al., 1996; Zhang and Klaassen, 2013). Holla
et al. (2001) have demonstrated that androgen-mediated
regulation of CYP4A arachidonate monooxygenases are
important to control systemic blood pressure. Berezan et al.
(2008) demonstrated that ovariectomy in aged normotensive
Sprague–Dawley rats increases Phenyl-induced vasoconstriction
via up-regulation of CYP4A expression, an effect that was
not reversed by estrogen treatment. In the present study, we
found similar results on CYP4A1 expression and activity, with
CYP4A1 being augmented in OVX-SHR and not modified by
CEE.
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FIGURE 3 | Representative fluorescent images (A) of nuclei labeled with ethidium produced by oxidation of dihydroethidium (DHE) by reactive oxygen species in
aortic sections of SHAM, ovariectomized (OVX), OVX treated with conjugated equine estrogens (CEE) and OVX treated with CEE plus testosterone (CEE+T) female
spontaneously hypertensive rats. Bar graphs show the densitometric analyses of fluorescence intensity of arteries after treatment with vehicle (B) and 1 µM of
HET0016, the CYP4A and CYP4F inhibitor (C). Results were expressed as percentage of SHAM and represent the mean ± SEM from 6–8 independent
experiments. One-way ANOVA: ∗P < 0.05.
FIGURE 4 | Immunoblot representative images (bottom) and densitometric analyses (top) of protein expression of CYP4A1 (A) and CYP4F3 (B), normalized by
α-actin, in aorta of SHAM, ovariectomized (OVX), OVX treated with conjugated equine estrogens (CEE) and OVX treated with CEE plus testosterone (CEE+T) female
spontaneously hypertensive rats. Results were expressed as percentage of SHAM and represent the mean ± SEM from 6 to 7 independent experiments. One-way
ANOVA: ∗P < 0.05.
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FIGURE 5 | mRNA levels of CYP4A1 (A) and CYP4F3 (B) normalized by GAPDH in aorta of SHAM, ovariectomized (OVX), OVX treated with conjugated equine
estrogens (CEE) and OVX treated with CEE plus testosterone (CEE+T) female spontaneously hypertensive rats. Results represent the mean ± SEM from 3 to 6
independent experiments. One-way ANOVA: ∗P < 0.05.
FIGURE 6 | Luminescence induced by CYP4A1 (A) and CYP4F3 (B) substrates, and (C) 20 HETE levels in aorta of SHAM, ovariectomized (OVX), OVX treated with
conjugated equine estrogens (CEE) and OVX treated with CEE plus testosterone (CEE+T) female spontaneously hypertensive rats. Enzyme activity is expressed in
percentage relative to the luminescence induced by recombinant CYP4A1 or CYP4F3 enzymes. Results represent the mean ± SEM from 3 to 6 independent
experiments performed in duplicate. One-way ANOVA: ∗P < 0.05.
There is evidence that increased vascular ROS generation
promoted by testosterone is associated with endothelial
dysfunction (Costa et al., 2015), contributing to changes in
blood pressure. In addition, an increase in ROS levels by
androgens has been reported in vascular smooth muscle
cells of Wistar and SHR male rats (Caplice et al., 2003;
Chignalia et al., 2012). In the present study, we showed that
adding testosterone to CEE therapy increases aortic ROS
generation, abolishing the vascular protective effects exerted
by estrogen. As established by our group, the increase of ROS
levels in the vasculature of OVX-SHR is mostly associated
to the up-regulation of NADPH oxidase subunits (Dantas
et al., 2004; Costa et al., 2015) and reduced antioxidants
enzymes (Ceravolo et al., 2012). In our previous study, we
interestingly observe that both CEE and CEE+T equally inhibit
the up-regulation of NADPH oxidase subunits NOX2 and
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FIGURE 7 | Illustrative image of testosterone effects in aorta of ovariectomized (OVX) Spontaneously Hypertensive Rat (SHR), a model of postmenopausal
hypertension. AA: acid arachidonic; 20-HETE: 20-hydroxyeicosatetraenoic acid; HET0016: N-hydroxy-N′-(4-n-butyl-2-methylphenyl)Formamidine; ROS, reactive
oxygen species; VSMC, vascular smooth muscle cells.
p22-phox in aortas of OVX-SHR, and therefore this mechanism
could not account for the increase in ROS production on
CEE+T-treated females SHR. In this regard, we proposed that
testosterone increases ROS generation by increasing NADPH
activity instead of modulating its expression (Costa et al.,
2015).
As endothelial CYP450 activity and expression can be
stimulated by hormones (Popp et al., 1998), and considering our
finding that 20-HETE modulates vasoconstriction in CEE+T-
treated OVX-SHR, we hypothesized that this pathway could
contribute to activate NADPH oxidase and increase ROS
generation. In fact, 20-HETE can activate NADPH oxidase
promoting ROS generation (Medhora et al., 2008; Toth
et al., 2013). Also, the increase of CYP-induced 20-HETE or
testosterone levels have been previously reported to induce ROS
production in blood vessels (Cheng et al., 2008; Medhora et al.,
2008; Costa et al., 2015). We observed that inhibition of 20-HETE
production by HET0016 decreased ROS generation elicited by
testosterone treatment. In the same way, HET0016 promotes
anti-oxidative effects directly in the cerebral microvasculature
(Toth et al., 2013). In cerebral circulation, the higher level of 20-
HETE promotes inflammation through ROS production (Toth
et al., 2013).
Different CYP isoforms have been described to generate
varying amounts of ROS in different tissues (Puntarulo
and Cederbaum, 1998). For example, CYP2C9 generates
ROS in coronary arteries (Fleming, 2001) and likewise
vascular dysfunction in Dahl salt-sensitive hypertensive rat
seems to be due to 20-HETE-mediated ROS production
(Williams et al., 2010; Lukaszewicz and Lombard, 2013).
In endothelial cells, CYP4F2 overexpression increases 20-
HETE and superoxide anion production by activation of
NADPH oxidase (Cheng et al., 2014). Also in the endothelium,
CYP2C contributes to the stretch-induced generation of
anion superoxide which has until now been attributed
to the activation of the NADPH oxidase (Hishikawa and
Lüscher, 1997; Hishikawa et al., 1997). The present study
was the first time to demonstrated that vascular dysfunction
and ROS generation in may also involve CYP4F3-derived
products.
Several studies have showed that there is an association among
androgen, CYP4A and CYP4F expression, 20-HETE synthesis
and hypertension (Holla et al., 2001; Nakagawa et al., 2003;
Zhou et al., 2005; Wu et al., 2013; Cheng et al., 2014). The
knowledge of sex hormones contribution to CYP4A and 4F
expression have improved our understanding of how these
enzymes are regulated by circulating hormone levels (Zhang
and Klaassen, 2013). For example, reduced plasmatic levels of
testosterone caused by castration, decreases mRNA expression
of CYP4A12A and 12B in liver and kidney. Similar effect
was observed in female-OVX treated with dihydrotestosterone
(Zhang and Klaassen, 2013). We demonstrated that ovariectomy
in SHR increases CYP4A1 activity up-regulating its mRNA and
protein expression. Curiously, estrogen therapy used in the
present study did not modify CYP4A1 activity and expression,
although the association of testosterone to CEE markedly
reduced CYP4A1.
On the other hand, protein expression of CYP4F3 was
augmented by estrogen therapy in OVX-SHR and potentiated
when testosterone added to CEE. This further increase of CYP4F3
expression in CEE+T was associated with an increase in CYP4F3
activity and 20-HETE and paralleled to the increased ROS
and Phenyl contraction observed in CEE+T rats. The CYP4F
enzyme is another subfamily of CYP that contributes to 20-HETE
synthesis (Harmon et al., 2006; Wu et al., 2014). A clinical study
in Chinese cohorts have shown a correlation of hypertension
in patients with CYP4F polymorphisms and elevated levels of
urinary 20-HETE (Liu et al., 2008; Deng et al., 2010). Similarly,
estrogen regulated CYP4F1, F4 and F6 expression (Kalsotra et al.,
2002) and androgen treatment induces CYP4F2 expression and
activity, leading to an enhance in urinary 20-HETE production
(Liu et al., 2012).
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The most intriguing point in this study was the observation
that change in hormone milieu (by OVX), estrogen and the
association of estrogen with testosterone have distinct effects
in different enzymes of CYP family, and that the variance in
the modulation of CYP4A and CYP4F may promote different
effects on vasoconstriction and ROS production. The cascade of
arachidonic acid (AA) is very complex and comprises a myriad
of enzymes which the tuning among them is still unknown.
When it goes to the branch of the Cytochrome P450 superfamily,
more complexity and lack of knowledge is added. Both CYP4A
and CYP4F are ω-hydroxylases that metabolize AA into several
hydroxy-eicosatetraenoic acids (HETEs), having many of them
vasoconstrictor properties (Roman, 2002; Nebert et al., 2013).
Although CYP4A1 has been described with the highest catalytic
efficiency to convert AA into 20-HETE, in our model (aorta of
female SHR) we found a direct association of increased 20-HETE
with an increase of CYP4F3 activity/expression. Our hypothesis
is that the increase of 20-HETE via CYP4F3 could account for
ROS generation in OVX-SHR treated with CEE+T, while the
increase of CYP4A1 in OVX and OVX treated with CEE could
favor the production of other HETEs that could contribute to
Phenyl contraction.
CONCLUSION
Our data confirms that association of testosterone to CEE
treated- OVX-SHR, a postmenopausal hypertensive model, rises
systolic and diastolic blood pressure and increases adrenergic
vasoconstriction and ROS generation in isolated aorta. The great
novelty of this study describes the contribution of CYP4F3-
derived synthesis of 20-HETE to the detrimental effects of
CEE+T therapy. Our studies call the scientific community
for the need of clinical studies to improve our knowledge
on the cardiovascular effects of the association of testosterone
to conventional hormone therapy in HSDD postmenopausal
women. Besides, our findings provide a rational that cytochrome
p-450 pathways/20-HETE synthesis may be an important
therapeutic target for prevention/treatment of cardiovascular
diseases in women in the presence of high levels of testosterone.
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